FDA to weigh easing limits on unproven peptides promoted by RFK Jr. Compounded "semaglutide" is not FDA approved semaglutide.com The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA considers adding a dozen peptides to its bulk drug compounding list RAPS Peptide Therapy in Boise Specialized Treatment for First Responders Blueline Wellness of the Federal Food, Drug, and Cosmetic Act (FDCA).*